aspirin
aspirin: 18 clinical trials tracked.
aspirin evidence translation
What we can confirm
18 tracked trials
What it means
What to watch
Prepared research question
What is verified about aspirin, and what remains unknown?
Traceable citations · Unknowns marked
See linked entities and source evidence8 indications · 5 study sponsors
Related indications
Clinical Trials (18)showing 10 most recent
A Phase 3, Multicenter, Double-Blinded, Randomized Study to Evaluate REGN7508, a Factor XI Monoclonal Antibody, Versus Acetylsalicylic Acid for Prophylaxis of Symptomatic Venous Thromboembolism After Elective Total Knee Arthroplasty (ROXI-ASPEN)
Primary endpoint: Incidence of the composite endpoint of symptomatic VTE and all-cause death
The Effect and Safety of Therapy Adding Cilostazol in Acute Ischemic Stroke Due to Large Artery Atherosclerosis: CHANGE Trial
Primary endpoint: Proportion of occurrence of composite endpoint
Safety and Efficacy of Treatment With Early Antiplatelet Administration After Intravenous Thrombolysis for Acute Ischemic Stroke (TREND-IVT): A Multicenter, Randomized, Placebo-controlled, Clinical Trial
Primary endpoint: The proportion of patients with a modified Rankin scale (mRS) score of 0-1 at 90-day follow up.
Study on Tirofiban With Aspirin in the Treatment of Acute Penetrating Artery Territory Infarction (STRATEGY)
Primary endpoint: new stroke or END(early neurological deterioration）
Tailored Versus Coventional AntiPlaTelet Strategy Intended After OPTIMIZEd Drug
Primary endpoint: Composite ischemic endpoint
COMParison of the EffecT of mEdication Therapy: Anticoagulation Versus Anti-platelet Versus Migraine Therapy in Alleviating Migraine With Patent Foramen Ovale
Primary endpoint: Responder rate
Randomized Multi-center Clinical Trial to Assess Effectiveness and Safety of Tirofiban Versus Intravenous Aspirin in Patients With Acute Ischemic Stroke Secondary to Tandem Injury, Subject to Recanalization Therapy Through Endovascular Treatment
Primary endpoint: Carotid Reocclusion
Defining a PGE2 Pathway in Regulating Eczema
Primary endpoint: Laboratory assessment of skin and blood of patients
Pilot Study to Assess the Efficacy of Aspirin to Improve Immunological Features of Ovarian Tumors
Primary endpoint: Change in intratumoral density of immunosuppressive T-regulatory (FOXP3+) cells from diagnostic biopsy to interval debulking surgery
Dual Antithrombotic Therapy With Dabigatran and Ticagrelor in Patients With Acute Coronary Syndrome and Non-valvular Atrial Fibrillation Undergoing Percutaneous Coronary Intervention (ADONIS-PCI)
Primary endpoint: Primary safety endpoint - first major or clinically relevant non-major bleeding event, as defined by the ISTH